Portage Biotech Stock (NASDAQ: PRTG) stock price, news, charts, stock research, profile.
You can purchase shares of Portage Biotech (NASDAQ:PRTG) through any online brokerage.
Other companies in Portage Biotech’s space includes: Vincerx Pharma (NASDAQ:VINC), Syros Pharmaceuticals (NASDAQ:SYRS), CERo Therapeutics Hldgs (NASDAQ:CERO), Galecto (NASDAQ:GLTO) and Alzamend Neuro (NASDAQ:ALZN).
Portage Biotech has a consensus price target of $14.50.
The stock price for Portage Biotech (NASDAQ: PRTG) is $5.87 last updated December 20, 2024 at 7:39 PM EST.
There are no upcoming dividends for Portage Biotech.
Portage Biotech’s Q3 earnings are confirmed for Wednesday, February 26, 2025.
There is no upcoming split for Portage Biotech.
Portage Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.